Fields »
ABOUT
HELP
BLOG

160 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 4 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ADPGKADP-dependent glucokinase
CentrosomeRenal cancer: 4.52e-7
Prostate cancer: 2.22e-4
Mixed
NCBP2Nuclear cap binding protein subunit 2, 20kDa
NucleoplasmLiver cancer: 2.37e-7
Prostate cancer: 2.27e-4
Pancreatic cancer: 4.75e-4
Expressed in all
WHAMMWAS protein homolog associated with actin, golgi membranes and microtubules
CytosolProstate cancer: 2.31e-4
Cervical cancer: 7.09e-4
Expressed in all
CCNT2Cyclin T2
Nucleoplasm
Plasma membrane
Cytosol		Renal cancer: 1.25e-5
Prostate cancer: 2.44e-4
Urothelial cancer: 3.28e-4
Expressed in all
PNNPinin, desmosome associated protein
Nuclear specklesProstate cancer: 2.44e-4
Liver cancer: 5.79e-4
Expressed in all
TGDSTDP-glucose 4,6-dehydratase
Nucleus
Nucleoli
Intermediate filaments		Prostate cancer: 2.48e-4
Expressed in all
PIGLPhosphatidylinositol glycan anchor biosynthesis, class L
Nucleoplasm
Cytosol		Renal cancer: 1.47e-4
Prostate cancer: 2.57e-4
Expressed in all
SYNJ1Synaptojanin 1
Nucleoplasm
Centrosome
Cytosol		Prostate cancer: 2.58e-4
Head and neck cancer: 4.43e-4
Tissue enhancedcerebral cortex:66.1
RUSC1RUN and SH3 domain containing 1
CytosolLiver cancer: 7.78e-6
Renal cancer: 9.24e-6
Prostate cancer: 2.65e-4
Expressed in all
GTPBP3GTP binding protein 3 (mitochondrial)
MitochondriaRenal cancer: 1.64e-4
Liver cancer: 1.86e-4
Prostate cancer: 2.81e-4
Expressed in all
EXO5Exonuclease 5
Nucleoplasm
Cytosol		Liver cancer: 9.16e-6
Prostate cancer: 2.93e-4
Mixed
CMSS1Cms1 ribosomal small subunit homolog (yeast)
Nucleus
Nuclear membrane
Nucleoli
Mitochondria		Liver cancer: 5.92e-10
Endometrial cancer: 3.15e-6
Prostate cancer: 3.10e-4
Expressed in all
MAP6D1MAP6 domain containing 1
CytosolProstate cancer: 3.37e-4
Group enriched7cerebral cortex:43.2
skeletal muscle:11.0
NELFCDNegative elongation factor complex member C/D
Nucleoplasm
Nuclear bodies
Vesicles
Cytosol		Endometrial cancer: 4.98e-5
Liver cancer: 1.90e-4
Prostate cancer: 3.37e-4
Expressed in all
TOB1Transducer of ERBB2, 1
Nucleoplasm
Vesicles		Pancreatic cancer: 5.04e-5
Prostate cancer: 3.37e-4
Expressed in all
ABCC5ATP-binding cassette, sub-family C (CFTR/MRP), member 5
Nucleus
Plasma membrane
Cell Junctions		Liver cancer: 6.78e-8
Prostate cancer: 3.40e-4
Expressed in all
RBM26RNA binding motif protein 26
Nuclear specklesRenal cancer: 5.87e-6
Prostate cancer: 3.46e-4
Urothelial cancer: 8.20e-4
Expressed in all
ZNF503Zinc finger protein 503
Nucleoplasm
Plasma membrane
Cytosol		Renal cancer: 1.97e-4
Prostate cancer: 3.50e-4
Mixed
SETD6SET domain containing 6
Nucleus
Cytosol		Prostate cancer: 3.54e-4
Expressed in all
ZNF440Zinc finger protein 440
NucleusRenal cancer: 1.18e-4
Prostate cancer: 3.57e-4
Urothelial cancer: 9.88e-4
Mixed
SIN3BSIN3 transcription regulator family member B
Nucleoplasm
Plasma membrane		Prostate cancer: 3.58e-4
Pancreatic cancer: 4.37e-4
Expressed in all
CCT2Chaperonin containing TCP1, subunit 2 (beta)
CytosolLiver cancer: 3.61e-9
Prostate cancer: 3.67e-4
Head and neck cancer: 8.38e-4
Expressed in all
RAD18RAD18 E3 ubiquitin protein ligase
Nucleoplasm
Nuclear bodies		Renal cancer: 3.65e-5
Liver cancer: 1.12e-4
Prostate cancer: 3.73e-4
Mixed
KIAA0907KIAA0907
NucleoplasmRenal cancer: 2.78e-10
Liver cancer: 1.01e-6
Urothelial cancer: 4.36e-5
Prostate cancer: 3.87e-4
Expressed in all
AK5Adenylate kinase 5
Microtubule organizing center
Cytosol		Prostate cancer: 3.88e-4
Tissue enriched9cerebral cortex:221.4
PRPF39Pre-mRNA processing factor 39
NucleoplasmLiver cancer: 3.84e-5
Urothelial cancer: 2.99e-4
Prostate cancer: 4.04e-4
Melanoma: 6.51e-4
Ovarian cancer: 8.48e-4
Mixed
DCUN1D5DCN1, defective in cullin neddylation 1, domain containing 5
Nucleus
Nucleoli		Liver cancer: 2.01e-7
Ovarian cancer: 9.52e-5
Prostate cancer: 4.12e-4
Head and neck cancer: 4.62e-4
Expressed in all
C3orf38Chromosome 3 open reading frame 38
Nucleoplasm
Plasma membrane
Cytosol		Ovarian cancer: 3.55e-4
Prostate cancer: 4.12e-4
Expressed in all
GPAT4Glycerol-3-phosphate acyltransferase 4
Ovarian cancer: 2.20e-4
Prostate cancer: 4.15e-4
Urothelial cancer: 5.65e-4
Endometrial cancer: 9.37e-4
Expressed in all
RFPL2Ret finger protein-like 2
Nuclear speckles
Plasma membrane		Prostate cancer: 4.16e-4
Tissue enriched9prostate:7.0
NCBP1Nuclear cap binding protein subunit 1, 80kDa
Nucleoplasm
Cytosol		Prostate cancer: 4.17e-4
Colorectal cancer: 5.28e-4
Expressed in all
ATP6V1E1ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1
NucleoplasmRenal cancer: 7.66e-8
Liver cancer: 1.56e-5
Prostate cancer: 4.18e-4
Expressed in all
ZNF195Zinc finger protein 195
Nucleus
Cytosol		Urothelial cancer: 4.79e-7
Liver cancer: 3.53e-5
Renal cancer: 7.89e-5
Prostate cancer: 4.24e-4
Expressed in all
SRSF4Serine/arginine-rich splicing factor 4
Nuclear specklesMelanoma: 3.27e-4
Prostate cancer: 4.26e-4
Renal cancer: 4.30e-4
Expressed in all
BCAS2Breast carcinoma amplified sequence 2
Nuclear speckles
Centrosome		Liver cancer: 8.23e-7
Prostate cancer: 4.27e-4
Thyroid cancer: 5.24e-4
Renal cancer: 6.49e-4
Ovarian cancer: 7.96e-4
Expressed in all
ASB9Ankyrin repeat and SOCS box containing 9
Nucleus
Cytosol		Prostate cancer: 4.36e-4
Tissue enhancedtestis:48.1
STAU1Staufen double-stranded RNA binding protein 1
CytosolProstate cancer: 4.41e-4
Expressed in all
CEP170BCentrosomal protein 170B
Centrosome
Cytosol		Renal cancer: 3.26e-4
Prostate cancer: 4.41e-4
Liver cancer: 6.12e-4
Mixed
TOP3ATopoisomerase (DNA) III alpha
Pancreatic cancer: 1.39e-4
Prostate cancer: 4.59e-4
Expressed in all
AKT2V-akt murine thymoma viral oncogene homolog 2
Nucleus
Vesicles
Cytosol		Endometrial cancer: 1.05e-6
Prostate cancer: 4.74e-4
Expressed in all
VCPKMTValosin containing protein lysine (K) methyltransferase
Lung cancer: 2.40e-4
Prostate cancer: 4.75e-4
Renal cancer: 6.79e-4
Mixed
MBD4Methyl-CpG binding domain 4 DNA glycosylase
Nuclear specklesRenal cancer: 2.73e-6
Pancreatic cancer: 2.18e-4
Prostate cancer: 4.75e-4
Expressed in all
CCDC174Coiled-coil domain containing 174
NucleoplasmUrothelial cancer: 3.81e-5
Prostate cancer: 4.75e-4
Expressed in all
CCDC14Coiled-coil domain containing 14
CentrosomeRenal cancer: 3.50e-8
Urothelial cancer: 2.72e-5
Prostate cancer: 4.76e-4
Liver cancer: 4.82e-4
Head and neck cancer: 5.27e-4
Expressed in all
METTL10Methyltransferase like 10
Nucleoplasm
Nuclear bodies		Thyroid cancer: 2.53e-4
Prostate cancer: 4.82e-4
Mixed
EXOGEndo/exonuclease (5'-3'), endonuclease G-like
Pancreatic cancer: 1.92e-5
Prostate cancer: 4.90e-4
Mixed
NCBP3Nuclear cap binding subunit 3
Nuclear specklesMelanoma: 4.68e-4
Prostate cancer: 4.90e-4
Expressed in all
SPAG16Sperm associated antigen 16
Plasma membrane
Cytosol		Renal cancer: 3.82e-4
Prostate cancer: 4.90e-4
Expressed in all
C1orf52Chromosome 1 open reading frame 52
NucleusRenal cancer: 1.17e-7
Liver cancer: 5.37e-5
Prostate cancer: 4.93e-4
Expressed in all
CEP83Centrosomal protein 83kDa
Nucleus
Golgi apparatus		Renal cancer: 5.00e-10
Prostate cancer: 4.98e-4
Expressed in all

« prev | Page of 4 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.